K2C8_HUMAN - dbPTM
K2C8_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID K2C8_HUMAN
UniProt AC P05787
Protein Name Keratin, type II cytoskeletal 8
Gene Name KRT8
Organism Homo sapiens (Human).
Sequence Length 483
Subcellular Localization Cytoplasm . Nucleus, nucleoplasm. Nucleus matrix.
Protein Description Together with KRT19, helps to link the contractile apparatus to dystrophin at the costameres of striated muscle..
Protein Sequence MSIRVTQKSYKVSTSGPRAFSSRSYTSGPGSRISSSSFSRVGSSNFRGGLGGGYGGASGMGGITAVTVNQSLLSPLVLEVDPNIQAVRTQEKEQIKTLNNKFASFIDKVRFLEQQNKMLETKWSLLQQQKTARSNMDNMFESYINNLRRQLETLGQEKLKLEAELGNMQGLVEDFKNKYEDEINKRTEMENEFVLIKKDVDEAYMNKVELESRLEGLTDEINFLRQLYEEEIRELQSQISDTSVVLSMDNSRSLDMDSIIAEVKAQYEDIANRSRAEAESMYQIKYEELQSLAGKHGDDLRRTKTEISEMNRNISRLQAEIEGLKGQRASLEAAIADAEQRGELAIKDANAKLSELEAALQRAKQDMARQLREYQELMNVKLALDIEIATYRKLLEGEESRLESGMQNMSIHTKTTSGYAGGLSSAYGGLTSPGLSYSLGSSFGSGAGSSSFSRTSSSRAVVVKKIETRDGKLVSESSDVLPK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Phosphorylation------MSIRVTQKS
------CCEEEEEEE
21.0725394399
6Phosphorylation--MSIRVTQKSYKVS
--CCEEEEEEEEEEE
22.0424732914
8AcetylationMSIRVTQKSYKVSTS
CCEEEEEEEEEEECC
46.5270083
8MethylationMSIRVTQKSYKVSTS
CCEEEEEEEEEEECC
46.5270083
8UbiquitinationMSIRVTQKSYKVSTS
CCEEEEEEEEEEECC
46.5221906983
9PhosphorylationSIRVTQKSYKVSTSG
CEEEEEEEEEEECCC
21.9921955146
10PhosphorylationIRVTQKSYKVSTSGP
EEEEEEEEEEECCCC
23.5727273156
11UbiquitinationRVTQKSYKVSTSGPR
EEEEEEEEEECCCCC
36.4821890473
11SumoylationRVTQKSYKVSTSGPR
EEEEEEEEEECCCCC
36.48-
11AcetylationRVTQKSYKVSTSGPR
EEEEEEEEEECCCCC
36.4818983182
11MethylationRVTQKSYKVSTSGPR
EEEEEEEEEECCCCC
36.4870071
11SumoylationRVTQKSYKVSTSGPR
EEEEEEEEEECCCCC
36.4828112733
11UbiquitinationRVTQKSYKVSTSGPR
EEEEEEEEEECCCCC
36.4821890473
13O-linked_GlycosylationTQKSYKVSTSGPRAF
EEEEEEEECCCCCCC
16.8331373491
13O-linked_GlycosylationTQKSYKVSTSGPRAF
EEEEEEEECCCCCCC
16.8320068230
13PhosphorylationTQKSYKVSTSGPRAF
EEEEEEEECCCCCCC
16.8328355574
14PhosphorylationQKSYKVSTSGPRAFS
EEEEEEECCCCCCCC
40.4621955146
15O-linked_GlycosylationKSYKVSTSGPRAFSS
EEEEEECCCCCCCCC
39.0231373491
15O-linked_GlycosylationKSYKVSTSGPRAFSS
EEEEEECCCCCCCCC
39.0220068230
15PhosphorylationKSYKVSTSGPRAFSS
EEEEEECCCCCCCCC
39.0221955146
18DimethylationKVSTSGPRAFSSRSY
EEECCCCCCCCCCCC
52.36-
18MethylationKVSTSGPRAFSSRSY
EEECCCCCCCCCCCC
52.3630762453
21PhosphorylationTSGPRAFSSRSYTSG
CCCCCCCCCCCCCCC
24.6927273156
22PhosphorylationSGPRAFSSRSYTSGP
CCCCCCCCCCCCCCC
20.8420201521
23MethylationGPRAFSSRSYTSGPG
CCCCCCCCCCCCCCC
32.2724129315
24PhosphorylationPRAFSSRSYTSGPGS
CCCCCCCCCCCCCCC
34.4120201521
25PhosphorylationRAFSSRSYTSGPGSR
CCCCCCCCCCCCCCC
12.1030278072
26PhosphorylationAFSSRSYTSGPGSRI
CCCCCCCCCCCCCCC
28.5828355574
27PhosphorylationFSSRSYTSGPGSRIS
CCCCCCCCCCCCCCC
34.4530278072
31PhosphorylationSYTSGPGSRISSSSF
CCCCCCCCCCCCCCC
29.5823927012
32MethylationYTSGPGSRISSSSFS
CCCCCCCCCCCCCCC
38.4324129315
34O-linked_GlycosylationSGPGSRISSSSFSRV
CCCCCCCCCCCCCCC
24.0630059200
34PhosphorylationSGPGSRISSSSFSRV
CCCCCCCCCCCCCCC
24.0628355574
35PhosphorylationGPGSRISSSSFSRVG
CCCCCCCCCCCCCCC
27.8523911959
36O-linked_GlycosylationPGSRISSSSFSRVGS
CCCCCCCCCCCCCCC
28.7230059200
36PhosphorylationPGSRISSSSFSRVGS
CCCCCCCCCCCCCCC
28.7230278072
37O-linked_GlycosylationGSRISSSSFSRVGSS
CCCCCCCCCCCCCCC
29.2330059200
37PhosphorylationGSRISSSSFSRVGSS
CCCCCCCCCCCCCCC
29.2328176443
39O-linked_GlycosylationRISSSSFSRVGSSNF
CCCCCCCCCCCCCCC
28.1830059200
39PhosphorylationRISSSSFSRVGSSNF
CCCCCCCCCCCCCCC
28.1828355574
40MethylationISSSSFSRVGSSNFR
CCCCCCCCCCCCCCC
34.5024129315
43PhosphorylationSSFSRVGSSNFRGGL
CCCCCCCCCCCCCCC
21.1730183078
44PhosphorylationSFSRVGSSNFRGGLG
CCCCCCCCCCCCCCC
33.7830278072
47Asymmetric dimethylarginineRVGSSNFRGGLGGGY
CCCCCCCCCCCCCCC
42.39-
47MethylationRVGSSNFRGGLGGGY
CCCCCCCCCCCCCCC
42.3924129315
54PhosphorylationRGGLGGGYGGASGMG
CCCCCCCCCCCCCCC
18.7027251275
58O-linked_GlycosylationGGGYGGASGMGGITA
CCCCCCCCCCCCEEE
32.3630059200
58PhosphorylationGGGYGGASGMGGITA
CCCCCCCCCCCCEEE
32.3630183078
60SulfoxidationGYGGASGMGGITAVT
CCCCCCCCCCEEEEE
4.0428183972
64PhosphorylationASGMGGITAVTVNQS
CCCCCCEEEEEECHH
20.5330183078
67PhosphorylationMGGITAVTVNQSLLS
CCCEEEEEECHHHHC
15.9824732914
71PhosphorylationTAVTVNQSLLSPLVL
EEEEECHHHHCCCEE
26.5226657352
74O-linked_GlycosylationTVNQSLLSPLVLEVD
EECHHHHCCCEEEEC
22.8330059200
74PhosphorylationTVNQSLLSPLVLEVD
EECHHHHCCCEEEEC
22.8328355574
89PhosphorylationPNIQAVRTQEKEQIK
CCCHHHCCCCHHHHH
34.19-
92AcetylationQAVRTQEKEQIKTLN
HHHCCCCHHHHHHHH
45.1327178108
92UbiquitinationQAVRTQEKEQIKTLN
HHHCCCCHHHHHHHH
45.1321906983
96UbiquitinationTQEKEQIKTLNNKFA
CCCHHHHHHHHHHHH
46.8021890473
97PhosphorylationQEKEQIKTLNNKFAS
CCHHHHHHHHHHHHH
36.0328188228
101UbiquitinationQIKTLNNKFASFIDK
HHHHHHHHHHHHHHH
41.0321890473
101N6-malonyllysineQIKTLNNKFASFIDK
HHHHHHHHHHHHHHH
41.03-
101AcetylationQIKTLNNKFASFIDK
HHHHHHHHHHHHHHH
41.0370067
101MalonylationQIKTLNNKFASFIDK
HHHHHHHHHHHHHHH
41.0321908771
101MethylationQIKTLNNKFASFIDK
HHHHHHHHHHHHHHH
41.0370067
101SumoylationQIKTLNNKFASFIDK
HHHHHHHHHHHHHHH
41.03-
101UbiquitinationQIKTLNNKFASFIDK
HHHHHHHHHHHHHHH
41.0321890473
104PhosphorylationTLNNKFASFIDKVRF
HHHHHHHHHHHHHHH
26.3528355574
108UbiquitinationKFASFIDKVRFLEQQ
HHHHHHHHHHHHHHH
30.4121890473
108AcetylationKFASFIDKVRFLEQQ
HHHHHHHHHHHHHHH
30.417705633
108UbiquitinationKFASFIDKVRFLEQQ
HHHHHHHHHHHHHHH
30.4121890473
117UbiquitinationRFLEQQNKMLETKWS
HHHHHHHHHHHHHHH
40.2921890473
117AcetylationRFLEQQNKMLETKWS
HHHHHHHHHHHHHHH
40.2923954790
117UbiquitinationRFLEQQNKMLETKWS
HHHHHHHHHHHHHHH
40.2921890473
122UbiquitinationQNKMLETKWSLLQQQ
HHHHHHHHHHHHHHH
25.9621890473
122AcetylationQNKMLETKWSLLQQQ
HHHHHHHHHHHHHHH
25.9627178108
122MethylationQNKMLETKWSLLQQQ
HHHHHHHHHHHHHHH
25.9670075
122SumoylationQNKMLETKWSLLQQQ
HHHHHHHHHHHHHHH
25.9628112733
122UbiquitinationQNKMLETKWSLLQQQ
HHHHHHHHHHHHHHH
25.9621890473
124PhosphorylationKMLETKWSLLQQQKT
HHHHHHHHHHHHHHH
22.2826657352
130UbiquitinationWSLLQQQKTARSNMD
HHHHHHHHHHHHCHH
39.5521890473
130SumoylationWSLLQQQKTARSNMD
HHHHHHHHHHHHCHH
39.55-
130AcetylationWSLLQQQKTARSNMD
HHHHHHHHHHHHCHH
39.5522424773
130SumoylationWSLLQQQKTARSNMD
HHHHHHHHHHHHCHH
39.5528112733
130UbiquitinationWSLLQQQKTARSNMD
HHHHHHHHHHHHCHH
39.5521890473
131PhosphorylationSLLQQQKTARSNMDN
HHHHHHHHHHHCHHH
23.9823909892
134PhosphorylationQQQKTARSNMDNMFE
HHHHHHHHCHHHHHH
33.7626657352
136SulfoxidationQKTARSNMDNMFESY
HHHHHHCHHHHHHHH
4.0928183972
139SulfoxidationARSNMDNMFESYINN
HHHCHHHHHHHHHHH
3.2528183972
142PhosphorylationNMDNMFESYINNLRR
CHHHHHHHHHHHHHH
21.7626657352
143PhosphorylationMDNMFESYINNLRRQ
HHHHHHHHHHHHHHH
10.6422199227
158AcetylationLETLGQEKLKLEAEL
HHHHCHHHHHHHHHH
42.9327178108
158UbiquitinationLETLGQEKLKLEAEL
HHHHCHHHHHHHHHH
42.9321890473
160UbiquitinationTLGQEKLKLEAELGN
HHCHHHHHHHHHHHH
56.1821906983
176UbiquitinationQGLVEDFKNKYEDEI
HHHHHHHHHHHHHHH
65.9221890473
176UbiquitinationQGLVEDFKNKYEDEI
HHHHHHHHHHHHHHH
65.9221890473
178MethylationLVEDFKNKYEDEINK
HHHHHHHHHHHHHHH
51.0815606719
178UbiquitinationLVEDFKNKYEDEINK
HHHHHHHHHHHHHHH
51.0821890473
179PhosphorylationVEDFKNKYEDEINKR
HHHHHHHHHHHHHHH
37.7020736484
185MethylationKYEDEINKRTEMENE
HHHHHHHHHHHCCCE
67.37-
185UbiquitinationKYEDEINKRTEMENE
HHHHHHHHHHHCCCE
67.37-
187PhosphorylationEDEINKRTEMENEFV
HHHHHHHHHCCCEEE
41.0921406692
189SulfoxidationEINKRTEMENEFVLI
HHHHHHHCCCEEEEE
7.1028183972
197AcetylationENEFVLIKKDVDEAY
CCEEEEEECCCCHHH
38.4726051181
197SumoylationENEFVLIKKDVDEAY
CCEEEEEECCCCHHH
38.4725114211
197UbiquitinationENEFVLIKKDVDEAY
CCEEEEEECCCCHHH
38.4721890473
198UbiquitinationNEFVLIKKDVDEAYM
CEEEEEECCCCHHHH
56.8621906983
204PhosphorylationKKDVDEAYMNKVELE
ECCCCHHHHCHHHHH
10.1226657352
207UbiquitinationVDEAYMNKVELESRL
CCHHHHCHHHHHHHH
22.1321890473
207AcetylationVDEAYMNKVELESRL
CCHHHHCHHHHHHHH
22.1319608861
207UbiquitinationVDEAYMNKVELESRL
CCHHHHCHHHHHHHH
22.1321890473
212PhosphorylationMNKVELESRLEGLTD
HCHHHHHHHHHHHHH
55.5822199227
218PhosphorylationESRLEGLTDEINFLR
HHHHHHHHHHHHHHH
42.3028176443
228PhosphorylationINFLRQLYEEEIREL
HHHHHHHHHHHHHHH
16.9820068231
237PhosphorylationEEIRELQSQISDTSV
HHHHHHHHHHCCCEE
41.9521815630
240PhosphorylationRELQSQISDTSVVLS
HHHHHHHCCCEEEEE
27.4826657352
242PhosphorylationLQSQISDTSVVLSMD
HHHHHCCCEEEEEEC
19.3424732914
243PhosphorylationQSQISDTSVVLSMDN
HHHHCCCEEEEEECC
18.4121955146
247PhosphorylationSDTSVVLSMDNSRSL
CCCEEEEEECCCCCC
16.6926657352
248SulfoxidationDTSVVLSMDNSRSLD
CCEEEEEECCCCCCC
5.0328183972
251PhosphorylationVVLSMDNSRSLDMDS
EEEEECCCCCCCHHH
20.9821955146
253PhosphorylationLSMDNSRSLDMDSII
EEECCCCCCCHHHHH
28.6530183078
256SulfoxidationDNSRSLDMDSIIAEV
CCCCCCCHHHHHHHH
5.4428183972
258PhosphorylationSRSLDMDSIIAEVKA
CCCCCHHHHHHHHHH
14.8420201521
264SumoylationDSIIAEVKAQYEDIA
HHHHHHHHHHHHHHH
22.6828112733
264UbiquitinationDSIIAEVKAQYEDIA
HHHHHHHHHHHHHHH
22.6821906983
267PhosphorylationIAEVKAQYEDIANRS
HHHHHHHHHHHHHHH
22.0427273156
274PhosphorylationYEDIANRSRAEAESM
HHHHHHHHHHHHHHH
35.3328355574
280PhosphorylationRSRAEAESMYQIKYE
HHHHHHHHHHHHCHH
29.8228355574
281SulfoxidationSRAEAESMYQIKYEE
HHHHHHHHHHHCHHH
1.8328183972
282PhosphorylationRAEAESMYQIKYEEL
HHHHHHHHHHCHHHH
19.1627273156
285SumoylationAESMYQIKYEELQSL
HHHHHHHCHHHHHHH
30.96-
285AcetylationAESMYQIKYEELQSL
HHHHHHHCHHHHHHH
30.9621466224
285MethylationAESMYQIKYEELQSL
HHHHHHHCHHHHHHH
30.9670079
285SumoylationAESMYQIKYEELQSL
HHHHHHHCHHHHHHH
30.9628112733
285UbiquitinationAESMYQIKYEELQSL
HHHHHHHCHHHHHHH
30.9621890473
286PhosphorylationESMYQIKYEELQSLA
HHHHHHCHHHHHHHC
19.1027273156
291PhosphorylationIKYEELQSLAGKHGD
HCHHHHHHHCHHCCH
32.5830576142
295UbiquitinationELQSLAGKHGDDLRR
HHHHHCHHCCHHHHH
38.5221890473
295AcetylationELQSLAGKHGDDLRR
HHHHHCHHCCHHHHH
38.5219608861
295SumoylationELQSLAGKHGDDLRR
HHHHHCHHCCHHHHH
38.5228112733
295UbiquitinationELQSLAGKHGDDLRR
HHHHHCHHCCHHHHH
38.5221890473
303PhosphorylationHGDDLRRTKTEISEM
CCHHHHHHHHHHHHH
35.5622817900
304SumoylationGDDLRRTKTEISEMN
CHHHHHHHHHHHHHH
42.20-
304AcetylationGDDLRRTKTEISEMN
CHHHHHHHHHHHHHH
42.2026051181
304SumoylationGDDLRRTKTEISEMN
CHHHHHHHHHHHHHH
42.2028112733
304UbiquitinationGDDLRRTKTEISEMN
CHHHHHHHHHHHHHH
42.2021890473
305PhosphorylationDDLRRTKTEISEMNR
HHHHHHHHHHHHHHH
37.6322817900
308PhosphorylationRRTKTEISEMNRNIS
HHHHHHHHHHHHHHH
25.2621815630
315PhosphorylationSEMNRNISRLQAEIE
HHHHHHHHHHHHHHC
30.4128355574
325UbiquitinationQAEIEGLKGQRASLE
HHHHCCHHHHHHHHH
64.9521890473
325AcetylationQAEIEGLKGQRASLE
HHHHCCHHHHHHHHH
64.9519608861
325SumoylationQAEIEGLKGQRASLE
HHHHCCHHHHHHHHH
64.9528112733
325UbiquitinationQAEIEGLKGQRASLE
HHHHCCHHHHHHHHH
64.9521890473
330PhosphorylationGLKGQRASLEAAIAD
CHHHHHHHHHHHHHC
29.0030278072
347AcetylationQRGELAIKDANAKLS
HHCCHHHHHHHHHHH
45.2223954790
347UbiquitinationQRGELAIKDANAKLS
HHCCHHHHHHHHHHH
45.2221906983
352UbiquitinationAIKDANAKLSELEAA
HHHHHHHHHHHHHHH
52.9721890473
352AcetylationAIKDANAKLSELEAA
HHHHHHHHHHHHHHH
52.9723954790
352UbiquitinationAIKDANAKLSELEAA
HHHHHHHHHHHHHHH
52.9721890473
354PhosphorylationKDANAKLSELEAALQ
HHHHHHHHHHHHHHH
39.1528857561
364SumoylationEAALQRAKQDMARQL
HHHHHHHHHHHHHHH
49.36-
364SumoylationEAALQRAKQDMARQL
HHHHHHHHHHHHHHH
49.36-
374PhosphorylationMARQLREYQELMNVK
HHHHHHHHHHHHCHH
10.8020068231
391PhosphorylationLDIEIATYRKLLEGE
HHHHHHHHHHHHCCC
9.2018083107
393SumoylationIEIATYRKLLEGEES
HHHHHHHHHHCCCHH
47.19-
393AcetylationIEIATYRKLLEGEES
HHHHHHHHHHCCCHH
47.1923749302
393SumoylationIEIATYRKLLEGEES
HHHHHHHHHHCCCHH
47.1928112733
393UbiquitinationIEIATYRKLLEGEES
HHHHHHHHHHCCCHH
47.1919608861
400PhosphorylationKLLEGEESRLESGMQ
HHHCCCHHHHHHHCC
37.5528355574
404PhosphorylationGEESRLESGMQNMSI
CCHHHHHHHCCCCEE
44.1221712546
406SulfoxidationESRLESGMQNMSIHT
HHHHHHHCCCCEEEE
3.4728183972
409SulfoxidationLESGMQNMSIHTKTT
HHHHCCCCEEEECCC
1.9328183972
410PhosphorylationESGMQNMSIHTKTTS
HHHCCCCEEEECCCC
20.8328355574
413PhosphorylationMQNMSIHTKTTSGYA
CCCCEEEECCCCCCC
28.5424732914
414UbiquitinationQNMSIHTKTTSGYAG
CCCEEEECCCCCCCC
35.33-
415PhosphorylationNMSIHTKTTSGYAGG
CCEEEECCCCCCCCC
27.6127966365
416PhosphorylationMSIHTKTTSGYAGGL
CEEEECCCCCCCCCC
23.0130175587
417PhosphorylationSIHTKTTSGYAGGLS
EEEECCCCCCCCCCC
34.7326657352
419PhosphorylationHTKTTSGYAGGLSSA
EECCCCCCCCCCCHH
11.2226657352
424PhosphorylationSGYAGGLSSAYGGLT
CCCCCCCCHHCCCCC
19.0520058876
425PhosphorylationGYAGGLSSAYGGLTS
CCCCCCCHHCCCCCC
30.4726657352
427PhosphorylationAGGLSSAYGGLTSPG
CCCCCHHCCCCCCCC
17.4221712546
431PhosphorylationSSAYGGLTSPGLSYS
CHHCCCCCCCCCCEE
35.8328355574
432PhosphorylationSAYGGLTSPGLSYSL
HHCCCCCCCCCCEEC
23.2428355574
436PhosphorylationGLTSPGLSYSLGSSF
CCCCCCCCEECCCCC
20.7030175587
437PhosphorylationLTSPGLSYSLGSSFG
CCCCCCCEECCCCCC
16.9821712546
438PhosphorylationTSPGLSYSLGSSFGS
CCCCCCEECCCCCCC
23.9121712546
441PhosphorylationGLSYSLGSSFGSGAG
CCCEECCCCCCCCCC
27.9930183078
442PhosphorylationLSYSLGSSFGSGAGS
CCEECCCCCCCCCCC
31.6530175587
445PhosphorylationSLGSSFGSGAGSSSF
ECCCCCCCCCCCCCC
24.3721712546
449PhosphorylationSFGSGAGSSSFSRTS
CCCCCCCCCCCCCCC
23.4422199227
450PhosphorylationFGSGAGSSSFSRTSS
CCCCCCCCCCCCCCC
34.1922199227
451PhosphorylationGSGAGSSSFSRTSSS
CCCCCCCCCCCCCCC
29.0121712546
453PhosphorylationGAGSSSFSRTSSSRA
CCCCCCCCCCCCCCE
36.2722199227
455PhosphorylationGSSSFSRTSSSRAVV
CCCCCCCCCCCCEEE
31.5924732914
456PhosphorylationSSSFSRTSSSRAVVV
CCCCCCCCCCCEEEE
25.8027273156
457PhosphorylationSSFSRTSSSRAVVVK
CCCCCCCCCCEEEEE
24.1928355574
458PhosphorylationSFSRTSSSRAVVVKK
CCCCCCCCCEEEEEE
24.8324732914
464AcetylationSSRAVVVKKIETRDG
CCCEEEEEEEEECCC
36.1022424773
465AcetylationSRAVVVKKIETRDGK
CCEEEEEEEEECCCC
33.8822424773
465UbiquitinationSRAVVVKKIETRDGK
CCEEEEEEEEECCCC
33.88-
468PhosphorylationVVVKKIETRDGKLVS
EEEEEEEECCCCEEC
37.2224719451
472SumoylationKIETRDGKLVSESSD
EEEECCCCEECCCCC
50.43-
472AcetylationKIETRDGKLVSESSD
EEEECCCCEECCCCC
50.4318983182
472SumoylationKIETRDGKLVSESSD
EEEECCCCEECCCCC
50.4325114211
472UbiquitinationKIETRDGKLVSESSD
EEEECCCCEECCCCC
50.4321890473
475O-linked_GlycosylationTRDGKLVSESSDVLP
ECCCCEECCCCCCCC
42.0419664994
475O-linked_GlycosylationTRDGKLVSESSDVLP
ECCCCEECCCCCCCC
42.0419664994
475PhosphorylationTRDGKLVSESSDVLP
ECCCCEECCCCCCCC
42.0419664994
477PhosphorylationDGKLVSESSDVLPK-
CCCEECCCCCCCCC-
25.0828355574
478PhosphorylationGKLVSESSDVLPK--
CCEECCCCCCCCC--
27.9028355574
483AcetylationESSDVLPK-------
CCCCCCCC-------
69.6618983182
483UbiquitinationESSDVLPK-------
CCCCCCCC-------
69.66-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
6TPhosphorylationKinaseAURKBQ96GD4
GPS
9SPhosphorylationKinasePRKCEQ02156
Uniprot
24SPhosphorylationKinasePRKCEQ02156
Uniprot
74SPhosphorylationKinasePRKCDQ05655
GPS
74SPhosphorylationKinaseMAPK-Uniprot
74SPhosphorylationKinaseMAP2K2P36507
GPS
74SPhosphorylationKinaseMAPK8P45983
GPS
74SPhosphorylationKinaseMAP2K1Q02750
GPS
74SPhosphorylationKinaseMAPK14Q16539
GPS
432SPhosphorylationKinaseMAPK-Uniprot
432SPhosphorylationKinaseAKT1P31749
PSP
432SPhosphorylationKinaseCAMK2-Uniprot
432SPhosphorylationKinaseMAPK8P45983
GPS
432SPhosphorylationKinaseMAPK3P27361
GPS
432SPhosphorylationKinaseMAPK1P63085
GPS
432SPhosphorylationKinaseERK2P28482
PSP
432SPhosphorylationKinaseCDK1P06493
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
74SPhosphorylation

11781324

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of K2C8_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
HS74L_HUMANHSPA4Lphysical
17353931
CLN5_HUMANCLN5physical
17353931
TPA_HUMANPLATphysical
9988531
KPCE_HUMANPRKCEphysical
1374067
ZN363_HUMANRCHY1physical
19282868
STAM2_HUMANSTAM2physical
22939629
K1C13_HUMANKRT13physical
25416956
K1C15_HUMANKRT15physical
25416956
K1H1_HUMANKRT31physical
25416956
KRT38_HUMANKRT38physical
25416956
TFP11_HUMANTFIP11physical
25416956
K1C40_HUMANKRT40physical
25416956
CAV1_HUMANCAV1physical
20808760

Drug and Disease Associations
Kegg Disease
OMIM Disease
215600Cirrhosis (CIRRH)
Kegg Drug
DrugBank
DB00031Tenecteplase
Regulatory Network of K2C8_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-117; LYS-207; LYS-295;LYS-325 AND LYS-347, AND MASS SPECTROMETRY.
Malonylation
ReferencePubMed
"The first identification of lysine malonylation substrates and itsregulatory enzyme.";
Peng C., Lu Z., Xie Z., Cheng Z., Chen Y., Tan M., Luo H., Zhang Y.,He W., Yang K., Zwaans B.M., Tishkoff D., Ho L., Lombard D., He T.C.,Dai J., Verdin E., Ye Y., Zhao Y.;
Mol. Cell. Proteomics 10:M111.012658.01-M111.012658.12(2011).
Cited for: MALONYLATION AT LYS-101.
N6-malonyllysine
ReferencePubMed
"The first identification of lysine malonylation substrates and itsregulatory enzyme.";
Peng C., Lu Z., Xie Z., Cheng Z., Chen Y., Tan M., Luo H., Zhang Y.,He W., Yang K., Zwaans B.M., Tishkoff D., Ho L., Lombard D., He T.C.,Dai J., Verdin E., Ye Y., Zhao Y.;
Mol. Cell. Proteomics 10:M111.012658.01-M111.012658.12(2011).
Cited for: MALONYLATION AT LYS-101.
Phosphorylation
ReferencePubMed
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-24; SER-43; SER-253;SER-432 AND SER-475, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21; SER-24; SER-27;SER-34; SER-36; SER-37; SER-43; SER-251; SER-253; SER-258; SER-274;SER-330; SER-400; SER-410; SER-432; SER-475 AND SER-478, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37; SER-43; SER-74;SER-253; SER-258 AND SER-274, AND MASS SPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13; THR-14; SER-21;SER-22; SER-24; THR-26; SER-34; SER-36; SER-37; SER-39; SER-43;SER-74; SER-243; SER-258; SER-330; SER-400; SER-410; SER-438; SER-441;SER-442; SER-456; SER-475 AND SER-478, AND MASS SPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-24 AND THR-26, AND MASSSPECTROMETRY.
"Phosphoproteome analysis of the human mitotic spindle.";
Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.;
Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-451, AND MASSSPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-253 AND SER-330, ANDMASS SPECTROMETRY.
"Global phosphoproteome of HT-29 human colon adenocarcinoma cells.";
Kim J.-E., Tannenbaum S.R., White F.M.;
J. Proteome Res. 4:1339-1346(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21; SER-22; SER-24;SER-37 AND SER-43, AND MASS SPECTROMETRY.
"Keratin 8 phosphorylation by p38 kinase regulates cellular keratinfilament reorganization: modulation by a keratin 1-like diseasecausing mutation.";
Ku N.O., Azhar S., Omary M.B.;
J. Biol. Chem. 277:10775-10782(2002).
Cited for: PHOSPHORYLATION AT SER-74, AND MUTAGENESIS OF LEU-72 AND SER-74.
"The intermediate filament protein keratin 8 is a novel cytoplasmicsubstrate for c-Jun N-terminal kinase.";
He T., Stepulak A., Holmstrom T.H., Omary M.B., Eriksson J.E.;
J. Biol. Chem. 277:10767-10774(2002).
Cited for: PHOSPHORYLATION AT SER-74.
"PKC epsilon-related kinase associates with and phosphorylatescytokeratin 8 and 18.";
Omary M.B., Baxter G.T., Chou C.F., Riopel C.L., Lin W.Y.,Strulovici B.;
J. Cell Biol. 117:583-593(1992).
Cited for: PHOSPHORYLATION AT SER-9 AND SER-24.
"Phosphorylation of human keratin 8 in vivo at conserved head domainserine 23 and at epidermal growth factor-stimulated tail domain serine431.";
Ku N.-O., Omary M.B.;
J. Biol. Chem. 272:7556-7564(1997).
Cited for: NUCLEOTIDE SEQUENCE [MRNA], AND PHOSPHORYLATION AT SER-24 AND SER-432.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-204 AND TYR-267, ANDMASS SPECTROMETRY.

TOP